What is the CVSS score of CVE-2018-14786?

CVE-2018-14786 has a CVSS 3.0 base score of 9.4 (Critical). CVSS vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H. EPSS exploitation probability: 3.1%.

Alaris Gs Firmware CVE-2018-14786

CRITICAL

Improper Authentication (CWE-287)

2018-08-23 ics-cert@hq.dhs.gov

Authentication Bypass Alaris Gs Firmware Alaris Gh Firmware Alaris Cc Firmware Alaris Tiva Firmware

9.4

CVSS 3.0 · NVD

Severity by source

NVD PRIMARY

9.4 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Aug 23, 2018 - 19:29 nvd

CRITICAL 9.4

DescriptionNVD

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

AnalysisAI

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication. Rated critical severity (CVSS 9.4), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Improper Authentication (CWE-287), which allows attackers to bypass authentication mechanisms to gain unauthorized access. Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port. Affected products include: Bd Alaris Gs Firmware, Bd Alaris Gh Firmware, Bd Alaris Cc Firmware, Bd Alaris Tiva Firmware.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Implement multi-factor authentication, enforce strong password policies, use proven authentication frameworks.